Wednesday - December 31, 2025

Nika Pharmaceuticals (OTCQB: NIKA) Targets Immune Health Breakthroughs Across HIV, Cancer, and Chronic Diseases

Nika Pharmaceuticals, Inc. (OTCQB: NIKA) is gaining investor attention as a next-generation biopharmaceutical company developing advanced immune-strengthening therapeutics for some of the world’s most critical diseases, including HIV/AIDS, Hepatitis B and C, Rheumatoid Arthritis, Cancer, and Diabetes. The company’s intellectual … Continue reading

Mjtrias Introduces Client-Centric Approach to Digital Services with Focus on Long-Term Partnerships

We believe that the most successful client relationships are built on deep understanding, mutual trust, and shared commitment to long-term success. Our new approach reflects that philosophy, moving beyond simple service delivery to genuine partnership that drives sustained business value. … Continue reading